Skip to main content
©Lovro77

Respiratory Diseases

The Foundation supports fundamental research projects on respiratory diseases - chronic or rare - to understand, prevent and explore new therapeutic approaches.

25

Supported projects by the Foundation since its creation in 2008

Develop a new therapeutic way against cystic fibrosis
 

Cystic fibrosis is the most common fatal genetic disease in western countries. It affects one out of every 2,500 births and patients have a 35-year life expectancy. There is currently no cure for cystic fibrosis. The Université Libre de Bruxelles studies the possibility for a treatment thanks to the discovery of a new type of antibodies, the nanobodies, smaller than usual antibodies.

this therapeutic approach would eliminate most symptoms of the disease, including respiratory symptoms
© Institut Pasteur/F. Gardy
© Institut Pasteur/F. Gardy

Fighting lung infections

The Air Liquide Foundation supports the Institut Pasteur of Paris to fight pulmonary bacterial infections. The objective of the research work is to study the action of proteins, antimicrobial peptides, on bacteria responsible for respiratory infections.

Expédition au coeur de l’Himalaya, sur les pentes du Manaslu (8163 m) © EXALT - Samuel Vergès

Improving Oxygenation at High Altitude


The Air Liquide Foundation supports a research project led by the Centre d’Expertise en Altitude (EXALT) regarding oxygenation in high altitude environments.The study tracked fifty volunteers in the Himalayan mountains, about 5500 meters above sea level, and measured cerebral and cardiac effects at high altitudes and also sleep cycle changes. A mask that increases expiratory pressure was also experimented, with the goal of raising blood oxygen concentration and thus facilitating the adaptation of organisms at high altitude.

The Air Liquide Foundation aided in the analysis of data collected during the expedition to Nepal as well as in the creation of this prototype pressurized expiration mask.
© T Rupp
Pressurized expiration mask enabling high-altitude adaptation © EXALT - Thomas Rupp
© Fondation Air Liquide

Air Liquide Foundation

Discover supported projects